abstract |
There is provided an HBV replication inhibitor of formula (I) comprising a stereochemically isomer, salt, hydrate, solvate thereof: In the formula, B, R 1 , R 2 and R 4 have the meanings defined herein. The present invention also relates to pharmaceutical compositions containing these inhibitors and to the use of HBV therapies alone or in combination with other HBV inhibitors. |